Oxford Clinical Trials Research Unit
We would like to make everyone aware that the OCTRU office continues to be contactable during the current situation regarding COVID-19.
If you have any queries please continue to contact us at octrutrialshub@ndorms.ox.ac.uk or for queries about specific trials, please contact the trial teams directly on the numbers on your information sheets or the trial websites.
Welcome
Welcome to the OCTRU website. The University of Oxford has a long standing tradition in clinical trials and OCTRU based within the University is one of the UKCRC's registered clinical trials units.
Latest News
Oxford receives NIHR funding to test anti-TNF on post operative delirium
27 July 2022
Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.
Emergency departments to use the FORCE pathway for wrist fractures in children
6 July 2022
New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.
Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination
29 June 2022
The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.
Celebrating Clinical Trials Day at NDORMS
20 May 2022
To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.
NIHR CTU SUPPORT
PLEASE NOTE: This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.
Recent OCTRU Publications
Surgical fixation with K-wires versus casting in adults with fracture of distal radius: DRAFFT2 multicentre randomised clinical trial.
Costa ML. et al, (2022), Bmj, 376
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
Hinks TSC. et al, (2021), Lancet respir med
TRAINING SESSIONS & SEMINARS
OCTRU Training Bite: Management of IMP and Relevant Documentation *ONLINE*
Tuesday, 20 September 2022, 10am to 11am
Would you like to collaborate with OCTRU?
OCTRU welcomes requests to collaborate, look to see which of our themes your collaboration may fit within.